ActHIB Articles
US pharmacists, drug wholesalers offer solutions to avoid disruption for Medicare beneficiaries
2 December 2009
BIO argues case for retaining “biosimilars” legislation in US health care reform package
3 November 2009
Allergan takes legal action against US govt over right to share info with physicians on Botox
5 October 2009
American College of Physicians makes recommendations to expand FDA’s authority, including stronger warnings on new drugs
29 September 2009
Canada should follow Switzerland and Netherland for sustainable health care, says think-tank
22 September 2009
The inside story on US health care reform from law firm
10 September 2009
Illinois court delays EC dispensing rule
16 April 2009
US FDA-related legislation in Congress
23 March 2009
Thailand group fights EU-ASEAN FTA
2 March 2009
Sun extends expiration date of Taro tender offer
12 January 2009
Waxman threat to drug DTC advertising
15 December 2008
US CHPA proposal "will not protect children"
20 October 2008
EC acts on freedom of pharmacies to set up
29 September 2008
NY state seeks pharma marketing reform
16 June 2008
DOR withdraws EMEA application for orBec
2 June 2008
NY Gov to curb gifts, etc to physicians in USA
26 May 2008
New US marketing rules for Rx drug plans
26 May 2008
Generic firm accused of false promotion
28 April 2008
US drugmakers opt for disclosure of grants
21 April 2008
PhRMA says marketing limits unnecessary
14 April 2008
Spain allows 274 more drugs to be advertised
3 March 2008
German pharmacy reform imposed by EC
18 February 2008
Japan stock market week to Nov 14
7 January 2008
Poland's drug market up 8.6% to $5.8 billion
10 December 2007
Reverse payment ban stalls in US Congress
19 November 2007
USA's CMS criticized for Part D "failures"
14 May 2007
Campaign to relax US Rx drug recycling regs
5 March 2007
$4 generics deal: 55 "too cheap" drugs withdrawn
18 December 2006
Information to patients debate in EU
2 October 2006
US conflict of interest row over NIH scientists
18 September 2006
Gov Schwarzenegger busy on California drugs and health care bills
11 September 2006
US drugmaker critics' challenged over conflict of interest
28 August 2006
Pfizer sued by Novo for patent infringement
7 August 2006
Drugmakers respond to WHO on artemisinin
22 May 2006
Amgen files with ITC to stop Roche's peg-EPO imports
17 April 2006
US FDA prohibits poultry antivirals
27 March 2006
US CMS warns over Rx plan marketing "tactics"
5 December 2005
Russia planning to mandate generic Rxing
5 September 2005
Americans OK DTC ban on new drug launches
1 August 2005
FDA challenged over Rx access for terminally-ill
25 July 2005
House votes US federal funding ban on ED drugs
4 July 2005
China to ban drug ads
14 March 2005
UPDATE: UK MHRA acts to curb unethical Rx ads
28 February 2005
US states seeking to ban Rx advertising
21 February 2005
Illinois claims price fraud against 48 drug firms
21 February 2005
Indian govt warns over drug marketing curbs
2 August 2004
US FDA's authorized generics move backed
19 July 2004
US FDA backs authorized generics, 180-day period
12 July 2004
Proportionality urged in EU trials directive
15 March 2004
UK tissue bill "could criminalize pharma"
1 March 2004
US Senate bill to allow govt Rx price power
16 February 2004
Michigan: five bills to act on drug prices
2 February 2004
Cellegy secures $15 million equity financing
26 January 2004
EU Court upholds ban on Internet Rx sales, OKs on-line and mail-order trade in OTCs
22 December 2003
Illegal cross-border trade threat to Canada's Rx supply, may violate trade deals: study
6 October 2003
EU Parliament votes to support stem cell research ban
21 April 2003
B-MS settles US FTC/states
17 March 2003
B-MS settles US FTC/states
17 March 2003
Organogenesis gets Amex delisting notice
6 January 2003
Florida Rx price statute "invalid," court hears
11 March 2002
P-I group files with EU against Pfizer
5 December 2001
Canadian clinical trials regs amended
27 September 2001
EU takes Greece to court over pharma tax
27 July 2001
Finland's pharma ad law questioned
23 March 2001
US Senate moves to amend FD&C Act
12 December 2000
Thai drugmakers view cost of PPA ban
11 December 2000
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
